SECOND EXTENSION OF letter of Lock-Up UndertakingLock-Up Undertaking • June 5th, 2023 • Regencell Bioscience Holdings LTD • Medicinal chemicals & botanical products
References are made in this second extension of letter of lock-up undertaking (this “Second Extension of Lock-Up Undertaking”) to (i) an agreement of option to purchase ordinary share of Regencell Bioscience Holdings Limited dated , under which the Company granted certain options (the “Options”) to purchase ordinary shares of the Company in the amounts set forth therein; (ii) a letter of lock-up undertaking by the Optionee dated , under which the Optionee undertook to the Company, within the period of one year and six months immediately following the closing of the initial public offering of the Company, not to, and to procure any entities controlled by the Optionee and any trusts of which the Optionee is a beneficiary not to, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of, or otherwise transfer or dispose of any of the Options or shares issued upon exercise of t
LOCK-UP UNDERTAKINGLock-Up Undertaking • December 24th, 2019 • Ma Kevin Xiaofeng • Services-educational services
Kevin Xiaofeng Ma, Able Knight Development Limited and Joingear Limited (together, the “Undertaking Shareholders”) refer to the Subscription Agreement entered into by and among the Company and certain Buyer dated December 15, 2019 (the “Subscription Agreement”). Unless otherwise stated, capitalized terms used in this Undertaking shall have the same meanings as defined in the Subscription Agreement.
LOCK-UP UNDERTAKINGLock-Up Undertaking • January 4th, 2021
Reference is made to section 5.1(e)(i)(D) of the Share Purchase Agreement (the “Agreement”) dated December 22, 2020 by and among The Caldwell Partners International Inc. (the “Corporation”), The Caldwell Partners International Ltd., David Windley, Chris Murdock, Tom Milic and Jeremy Conner in connection with the purchase of all issued and outstanding shares in the capital of IQTalent Partners, Inc. Capitalized terms used herein have the meanings set out in the Agreement, unless otherwise expressly defined herein. The execution and delivery by the undersigned of this Undertaking is a condition to the closing of the transaction contemplated in the Agreement.
FORM OF LETTER OF LOCK-UP UNDERTAKINGLock-Up Undertaking • May 16th, 2022 • Regencell Bioscience Holdings LTD • Medicinal chemicals & botanical products • New York
Pursuant to an agreement of option to purchase ordinary share of Regencell Bioscience Holdings Limited dated June 9, 2021, the Company granted to the Optionee certain options (the “Options”) to purchase ordinary shares of the Company in the amounts set forth therein.
FORM OF LETTER OF LOCK-UP UNDERTAKINGLock-Up Undertaking • December 15th, 2023 • Regencell Bioscience Holdings LTD • Medicinal chemicals & botanical products
References are made in this third extension of letter of lock-up undertaking (this “Third Extension of Lock-Up Undertaking”) to (i) an agreement of option to purchase ordinary share of Regencell Bioscience Holdings Limited dated , under which the Company granted certain options (the “Options”) to purchase ordinary shares of the Company in the amounts set forth therein; (ii) a letter of lock-up undertaking by the Optionee dated , under which the Optionee undertook to the Company, within the period of one year and six months immediately following the closing of the initial public offering of the Company, not to, and to procure any entities controlled by the Optionee and any trusts of which the Optionee is a beneficiary not to, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of, or otherwise transfer or dispose of any of the Options or shares issued upon exercise of the
